<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04858802</url>
  </required_header>
  <id_info>
    <org_study_id>P500-1220</org_study_id>
    <nct_id>NCT04858802</nct_id>
  </id_info>
  <brief_title>A Clinical Evaluation of PROPEL® Contour Sinus Implant</brief_title>
  <acronym>EXPAND</acronym>
  <official_title>The EXPAND Study: A Clinical Evaluation of PROPEL® Contour Sinus Implant Placement in the Frontal Sinus Ostium Following In-office Bilateral Balloon Dilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intersect ENT</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intersect ENT</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the efficacy of PROPEL Contour Sinus Implant&#xD;
      placement in the frontal sinus ostia following dilation in patients with chronic&#xD;
      rhinosinusitis (CRS)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, randomized, single-blind (blinded Independent Reviewer), intra-patient&#xD;
      controlled, multicenter post-market study with 80 randomized subjects at up to 15 study&#xD;
      centers.&#xD;
&#xD;
      After successful in-office bilateral balloon dilation of the frontal sinus ostium (FSO) using&#xD;
      the VenSure™ Nav Balloon Device and Fiagon Cube Navigation System, patients will be&#xD;
      randomized to receive one PROPEL Contour Sinus Implant on one side while the contralateral&#xD;
      side serves as the control.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 12, 2021</start_date>
  <completion_date type="Anticipated">August 19, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 11, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Intrapatient control in which eligible subjects will receive the PROPEL Contour Sinus Implant (Treatment) on one side, and no implant (Control) on the contralateral side.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference of FSO area</measure>
    <time_frame>Day 45</time_frame>
    <description>Side-to-side difference in FSO area (anterior to posterior and lateral dimension) will be assessed by a blinded independent reviewer using CT scans collected at Day 45 to measure maximum diameter in mm of the FSO using precise measurement of the anterior to posterior dimensions in the sagittal plane of the os as well as a medial to lateral measurement by coronal plane.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frontal Disease Assessment</measure>
    <time_frame>Days 45 and 180</time_frame>
    <description>Lund-MacKay score using Radiological Grading Scale assessed by blinded independent reviewer at Days 45 and 180 to assess extent of the disease in the frontal sinuses</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Chronic Rhinosinusitis (Diagnosis)</condition>
  <arm_group>
    <arm_group_label>PROPEL Contour Sinus Implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following successful in-office bilateral balloon dilation, placement of PROPEL Contour Sinus Implant in the randomized side.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Balloon Sinus Dilation Alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Following successful in-office bilateral balloon dilation, placement of no implant on the contralateral side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PROPEL Contour Sinus Implant</intervention_name>
    <description>370 mcg mometasone furoate-coated sinus implant</description>
    <arm_group_label>PROPEL Contour Sinus Implant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Balloon Sinus Dilation Alone</intervention_name>
    <description>No sinus implant</description>
    <arm_group_label>Balloon Sinus Dilation Alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient is 18 years of age or older.&#xD;
&#xD;
          2. Patient is willing and able to comply with protocol requirements.&#xD;
&#xD;
          3. Patient has confirmed diagnosis of CRS per International Consensus Statement on&#xD;
             Allergy and Rhinology, Rhinosinusitis 2016 (ICAR:RS) guidelines.&#xD;
&#xD;
          4. Bilateral disease in the frontal sinuses (Lund-Mackay CT score of ≥1 on each side) on&#xD;
             CT scan within 90 days prior to enrollment.&#xD;
&#xD;
          5. A successfully completed in-office balloon dilation of the bilateral FSO with no&#xD;
             complication on either side that, in the opinion of the clinical investigator is&#xD;
             amenable for PROPEL Contour Sinus Implant placement.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Nasal polyps or other physical anomaly that precludes FSO endoscopic visualization.&#xD;
&#xD;
          2. Oral-steroid dependent condition such as chronic obstructive pulmonary disease (COPD)&#xD;
             or other conditions.&#xD;
&#xD;
          3. Known history of allergy or intolerance to corticosteroids or mometasone furoate.&#xD;
&#xD;
          4. Patients with a known hypersensitivity to lactide, glycolide or caprolactone&#xD;
             copolymers.&#xD;
&#xD;
          5. Patients with electronic devices in direct connection to the brain or the nervous&#xD;
             system such as implantable neurostimulators (e.g. deep brain stimulation),&#xD;
             programmable CSF shunts.&#xD;
&#xD;
          6. Patients with monopolar pacemakers (older designs, with lower resistance to&#xD;
             interference) or ICD's (implantable cardioverter defibrillator).&#xD;
&#xD;
          7. Patients with implantable, body worn devices such as insulin pumps.&#xD;
&#xD;
          8. Evidence of purulence coming from paranasal sinuses or ostiomeatal complex.&#xD;
&#xD;
          9. Clinical evidence of acute bacterial sinusitis or invasive fungal sinusitis (e.g. bone&#xD;
             erosion on prior CT scan, necrotic sinus tissue).&#xD;
&#xD;
         10. Active viral illness (e.g., flu, shingles).&#xD;
&#xD;
         11. Use of parenteral or injected steroids (e.g. Kenalog) 30 days prior to the baseline&#xD;
             procedure.&#xD;
&#xD;
         12. Use of oral steroids, budesonide or other sinus steroid irrigations/rinses or drops,&#xD;
             nebulized steroids administered nasally 14 days prior to baseline procedure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xiaomin Deng, PhD</last_name>
    <phone>650-407-0285</phone>
    <email>xdeng@intersectent.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Gawlicka, PhD, MBA</last_name>
    <phone>650-701-4171</phone>
    <email>agawlicka@intersectent.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sacramento ENT/DaVinci Research, LLC</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95815</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>San Francisco Otolaryngology</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Colorado ENT &amp; Allergy</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80923</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ENT &amp; Allergy Associate of Florida, LLC</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33487</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ENT &amp; Allergy Associate of Florida, LLC</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33426</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ENT of Georgia</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ascentist Physicians Group</name>
      <address>
        <city>Leawood</city>
        <state>Kansas</state>
        <zip>66211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kentuckiana Ear, Nose &amp; Throat PSC</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Advanced ENT &amp; Allergy</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Coastal Ear, Nose &amp; Throat</name>
      <address>
        <city>Holmdel</city>
        <state>New Jersey</state>
        <zip>07733</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Madison ENT</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ohio Sinus Institute</name>
      <address>
        <city>Dublin</city>
        <state>Ohio</state>
        <zip>43016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Collin County ENT</name>
      <address>
        <city>Frisco</city>
        <state>Texas</state>
        <zip>75034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ENT Associates of Texas</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75070</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alamo ENT Associates</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 21, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Frontal Sinus</keyword>
  <keyword>Balloon Dilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

